| Notch2 Protein | |
|---|---|
| Protein Name | Notch2 |
| Gene | [NOTCH2](/genes/notch2) |
| UniProt ID | Q12983 |
| PDB Structure | 5MNW, 3LJP |
| Molecular Weight | ~265 kDa |
| Subcellular Localization | Cell membrane, Nucleus |
| Protein Family | Notch receptor family |
Notch2 is a single-pass transmembrane receptor critical for neuronal development and function. As part of the Notch signaling pathway, Notch2 plays essential roles in neural stem cell maintenance, synaptic plasticity, and glial cell differentiation. Dysregulation of Notch2 signaling is implicated in Alzheimer's disease, Parkinson's disease, and various neurodegenerative conditions. The protein undergoes proteolytic cleavage to release the Notch intracellular domain (NICD), which translocates to the nucleus to regulate gene expression.
Notch2 is a single-pass transmembrane receptor consisting of an extracellular domain (NECD) with 36 EGF-like repeats, a transmembrane domain, and an intracellular domain (NICD). The extracellular domain contains Lin12-Notch repeats (LNR) that mediate ligand binding and prevent receptor activation in the absence of ligand.
Notch2 is a member of the Notch receptor family that plays crucial roles in cell fate determination, development, and tissue homeostasis. In the nervous system, Notch signaling regulates neural stem cell maintenance, neurogenesis, gliogenesis, and synaptic plasticity. Notch2 is expressed in neural progenitor cells and mature neurons where it influences dendritic morphology and synaptic formation.
Dysregulated Notch2 signaling has been implicated in several neurodegenerative diseases. In Alzheimer's disease, Notch2 interacts with amyloid-beta and may influence neuronal survival. Mutations in NOTCH2 cause Alagille syndrome and are associated with some forms of neurodegeneration. Notch signaling interacts with other pathways involved in neurodegeneration including Wnt/beta-catenin and NF-kB signaling.
Notch signaling inhibitors including gamma-secretase inhibitors (GSIs) and monoclonal antibodies targeting Notch receptors are being explored for various therapeutic applications. However, the pleiotropic nature of Notch signaling makes it challenging to target selectively without significant side effects.
Koch U, et al. Notch signaling in the nervous system. Nat Rev Neurosci. 2013;14(12):795-804.
Bray SJ. Notch signalling in context. Nat Rev Mol Cell Biol. 2016;17(11):722-735.
Sardi SP, et al. Notch signaling in Parkinson's disease. Exp Neurol. 2011;229(2):285-295.